Specific Overview

  • Founded
  • 2011

  • Status
  • Acquired/​Merged

  • Employees
  • 68

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $370M

Specific General Information


Developer of diagnostic equipment designed to streamline lab workflows in determining the effectiveness of antibiotics in treating sepsis. The company's product includes an instrument and assay that responds to the metabolic byproducts produced by microorganisms to detect growth, assess antibiotic efficacy, and determine microorganism ID, enabling doctors to shorten the time from sample arrival to a selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • 130 Baytech Drive
  • San Jose, CA 95134
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Specific Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 19-May-2022 $370M 000.00 00000 Completed Generating Revenue
6. Grant 02-Jun-2020 00.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series A) 06-Sep-2019 000.00 000.00 000.00 Completed Generating Revenue
4. Grant 07-Aug-2019 00.00 Completed Generating Revenue
3. Grant 07-Feb-2017 00000 Completed Generating Revenue
2. Grant 01-Jan-2017 $3.99M Completed Generating Revenue
1. Grant 01-Jan-2013 $145K Completed Generating Revenue
To view Specific’s complete valuation and funding history, request access »

Specific Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 000
To view Specific’s complete cap table history, request access »

Specific Comparisons

HQ Location
Total Raised
Post Valuation
Developer of diagnostic equipment designed to streamline lab workflows in determining the effectiveness of antibiotics i
Diagnostic Equipment
San Jose, CA
68 As of 2022
0000 0000-00-00
000000&0 000.00


strud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000000000 000000000
Cincinnati, OH
000 As of 0000
0.000 0000-00-00


psum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididu
Hayward, CA
000 As of 0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Specific Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Meridian Bioscience Private Equity-Backed Cincinnati, OH 000 000000&0
000000 Venture Capital-Backed Hayward, CA 000 0000 00000000000 0000
You’re viewing 2 of 2 competitors. Get the full list »

Specific Executive Team (5)

Name Title Board Seat Contact Info
Paul Rhodes Ph.D Co-Founder & Chief Executive Officer
Johnny Ek Chief Financial Officer
Anthony Bazarko Co-Chief Commercial Officer & Advisor
Scott O'Brien Co-Chief Commercial Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Specific Board Members (2)

Name Representing Role Since
Kenneth Suslick Ph.D Specific Member of US Scientific Advisory Board 000 0000
Paul Grossman Ph.D Telegraph Hill Partners Board Member 000 0000
To view Specific’s complete board members history, request access »

Specific Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Specific Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CARB-X University 000 0000 000000 0
National Institute for Allergy and Infectious Disease Government 000 0000 000000 0
Telegraph Hill Partners Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Specific’s complete investors history, request access »